Prion Diseases pp 209-216 | Cite as

PrPSc typing by N-terminal sequencing and mass spectrometry

  • S. G. Chen
  • W. Zou
  • P. Parchi
  • P. Gambetti
Part of the Archives of Virology. Supplementa book series (ARCHIVES SUPPL, volume 16)


The heterogeneity of the clinicopathological phenotype in human prion diseases is associated with the presence of the different forms of the abnormal prion protein, PrPSc. We have previously shown that PrPSc in FFI and a subtype of familial CJD linked to the D178N mutation can be distinguished by their difference in gel mobility following proteinase K (PK) treatment. To further characterize the structural difference of PrPSc in familial prion diseases, N-terminal sequencing and mass spectrometry were used to identify the protease cleavage sites in PrPSc extracted from affected brains. We found that the main PK cleavage sites of PrPSc are located at residue 97 in FFI, and residue 82 in both CJD178 and a GSS subtype linked to the P102L mutation. The differential accessibility to protease in the native PrPSc suggests that PrPSc exist as distinct conformers in different disease states.


Prion Protein Prion Disease Bovine Spongiform Encephalopathy Fatal Familial Insomnia Human Prion Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bolton DC, Bendheim PE, Marmorstein AD, Potempska A (1987) Isolation and structural studies of the intact scrapie agent protein. Arch Biochem Biophys 258: 579–590PubMedCrossRefGoogle Scholar
  2. 2.
    Bruce ME, McConnell I, Fraser H, Dickinson AG (1991) The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72: 595–603PubMedCrossRefGoogle Scholar
  3. 3.
    Chen SG, Parchi P, Brown P, Capellari S, Zou W, Cochran EJ, Vnencak-Jones CL, Mien J, Vital C, Mikol J, Lugaresi E, Autilio-Gambetti L, Gambetti P (1997) Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nature Med 3: 1009–1015PubMedCrossRefGoogle Scholar
  4. 4.
    Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270: 19173–19180PubMedCrossRefGoogle Scholar
  5. 5.
    Cohen FE, Prusiner SB (1998) Pathologic conformations of prion proteins. Annu Rev Biochem 67: 793–819PubMedCrossRefGoogle Scholar
  6. 6.
    Collinge J, Sidle KC, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383: 685–690PubMedCrossRefGoogle Scholar
  7. 7.
    Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, Cohen FE, Prusiner SB, Wright PE, Dyson HJ (1997) Structure of the recombinant full-length hamster prion protein PrP(29–231): the N terminus is highly flexible. Proc Natl Acad Sci USA 94: 13452–13457PubMedCrossRefGoogle Scholar
  8. 8.
    Ghetti B, Dlouhy SR, Giaccone G, Bugiani O, Frangione B, Farlow MR, Tagliavini F (1995) Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol 5: 61–75PubMedCrossRefGoogle Scholar
  9. 9.
    Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Willis PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258: 806–808PubMedCrossRefGoogle Scholar
  10. 10.
    Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, Schulz-Schaeffer W, Kretzschmar H, Raeber A, Braun U, Ehrensperger F, Hornemann S, Glocksh-uber R, Riek R, Billeter M, Wüthrich K, Oesch B (1997) Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390: 74–77PubMedCrossRefGoogle Scholar
  11. 11.
    Liu H, Farr-Jones S, Ulyanov NB, Llinas M, Marqusee S, Groth D, Cohen FE, Prusiner SB, James TL (1999) Solution structure of Syrian hamster prion protein rPrP(90–231). Biochemistry 38: 5362–5377PubMedCrossRefGoogle Scholar
  12. 12.
    McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35: 57–62PubMedCrossRefGoogle Scholar
  13. 13.
    Monari L, Chen SG, Brown P, Parchi P, Petersen RB, Mikol J, Gray F, Cortelli P, Montagna P, Ghetti B, Goldfarb LG, Gajdusek DC, Lugaresi E, Gambetti P, Autilio-Gambetti L (1994) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 91: 2839–2842PubMedCrossRefGoogle Scholar
  14. 14.
    Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90: 10962–10966PubMedCrossRefGoogle Scholar
  15. 15.
    Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, Brown P, Kitamoto T, Tateishi J, Giese A, Kretzschmar H (1997) Typing prion isoforms. Nature 386: 232–234PubMedCrossRefGoogle Scholar
  16. 16.
    Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39: 767–778PubMedCrossRefGoogle Scholar
  17. 17.
    Parchi P, Chen SG, Brown P, Zou W, Capellari S, Budka H, Hainfellner J, Reyes PF, Golden GT, Hauw JJ, Gajdusek DC, Gambetti P (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci USA 95: 8322–8327PubMedCrossRefGoogle Scholar
  18. 18.
    Prusiner SB (1991) Molecular biology of prion diseases. Science 252: 1515–1522PubMedCrossRefGoogle Scholar
  19. 19.
    Prusiner SB (1998) The prion diseases. Brain Pathol 8: 499–513PubMedCrossRefGoogle Scholar
  20. 20.
    Puckett C, Concannon P, Casey C, Hood L (1991) Genomic structure of the human prion protein gene. Am J Hum Genet 49: 320–329PubMedGoogle Scholar
  21. 21.
    Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K (1996) NMR structure of the mouse prion protein domain PrP(121–-321). Nature 382: 180–182PubMedCrossRefGoogle Scholar
  22. 22.
    Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr (1993) Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci 2: 2206–2216PubMedCrossRefGoogle Scholar
  23. 23.
    Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nature Med 4: 1157–1165PubMedCrossRefGoogle Scholar
  24. 24.
    Tagliavini F, Prelli F, Porro M, Rossi G, Giaccone G, Farlow MR, Dlouhy SR, Ghetti B, Bugiani O, Frangione B (1994) Amyloid fibrils in Gerstmann-Straussler- Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79: 695–703PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • S. G. Chen
    • 1
  • W. Zou
    • 1
  • P. Parchi
    • 1
  • P. Gambetti
    • 1
  1. 1.Division of Neuropathology, Institute of PathologyCase Western Reserve UniversityClevelandUSA

Personalised recommendations